Studies were included if they were randomized controlled trials (RCTs) or clinical trials evaluating the role of human albumin infusion in patients with decompensated cirrhosis, acute-on-chronic liver failure (ACLF), refractory ascites, or hepatorenal syndrome type 1 (HRS-1). Here, ALB is linked to acute-on-chronic liver failure.